Jeff Pavell Hoth Therapeutics, Inc. (HOTH) insider trading activity
Jeff Pavell is Director of Hoth Therapeutics, Inc.. Currently has a direct ownership of 5,075 shares of HOTH, which is worth approximately $4,009. The most recent transaction as insider was on Dec 13, 2022, when has been sold 5,075 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
5.08K
0%
3M change
0%
12M change
Total Value Held
$4,009
JP
Jeff Pavell
Director
New York, NY